Longport
is committed to provide its potential and current customers with information
regarding its technology, the use and benefits of high resolution ultrasound
imaging and the implementation of our products into clinical applications.
They are doing this through information handouts, direct customer dialogue,
collaborative studies with leading medical centers and the resultant
papers and presentations that arise, system and application training
as well as this web site. They are committed to the advancement of this
exciting new technology and hope you are able to take advantage of the
information we are providing.
O
V E R V I E W
The EPISCAN®
has been developed to examine the human skin and first few centimeters
of subdermal soft tissue using ultrasound with three alternative transducers
of centre frequency range 20MHz, 35 MHz and 45 MHz. The system can resolve
features down to 40 microns and displays the digitised information obtained
as B scans. 
Principal
uses are in skin cancer, plastic surgery, dermatology including aesthetic
applications and in nursing and wound care, especially
in the early detection, prevention and treatment of pressure sores.
The region that the EPISCAN®
has been designed to image, although including the body's largest organ,
the skin, and the subject of countless diseases and traumas, is virtually
neglected in regard to imaging instrumentation. To date only optical imaging
has been widely applied and this exclusively provides the clinician with
surface data. Information from below the surface is normally only obtained
through biopsies and the subsequent preparation of tissue slides.
Ultrasound Biomicroscopy
is a technique that utilises high frequency diagnostic ultrasound to examine
living tissue at a microscopic level. Ultrasound medical imaging has been
used for many years. It is probably best know as a tool for fetal imaging.
It has been shown to be safe, reliable and cost effective. High frequency
ultrasound takes this tool to a new level. Longport's technology utilises
ultrasound at frequencies up to 50MHz that allows for imaging tissue at
a resolution down to
40 microns. Scientists and health care professionals have been seeking
a way to examine tissue at a microscopic level without the need to perform
damaging biopsies. High resolution ultrasound allows for a non-invasive
biopsy to be performed on tissue to a depth to 2 to 3 centimeters.
High resolution
ultrasound images detail the layers of the skin and subcutaneous tissue.
Subtle changes in thickness, density and fluid content can be clearly
appreciated. This information can be utilised for a number of reasons.
The human skin is the largest organ of the body. Pathology like chronic
wounds, burns, skin cancers and skin lesions are very common. Also, the
skin is affected by a number of systemic diseases making it a great indicator
of these afflictions. High resolution ultrasound images provide the clinician
with detailed anatomical information that can lead to better and more
accurate treatments.
|
Photos
showing computer screen images obtained with 35MHz transducer.
|
|
|
 |
 |
| forearm showing
longitudinal section of tendon and underlying muscles |
skin
lesions
|
R
A N G E O F A P P L I C A T I O N S
Many clinical disciplines are expected to benefit from the use of
the EPISCAN®.
These include the following groupings, representative of whom Longport
has met with to discuss the role of the EPISCAN®.
| Speciality |
Episcan®
Applications |
Q.Light®
Phototherapy Applications |
Chronic
Wound Care
Doctors and Nurses |
Assessment
and monitoring of wounds |
Q.Light®
Wound care with and without infra-red. |
| Plastic
Surgeons |
Tissue
assessment surgery and monitoring of burns |
Q.Light®
Wound care with and without infra-red. |
| Oncologists |
Mapping
of skin tumours |
Q.Light®
Skin Cancer PDT assessment and treatment filters |
| Podiatrists |
Lower
extremity ulcers including pressure ulcers, venous stasis, diabetic
ulcers, tendon and ligament injuries |
Q.Light®
Wound care with and without infra-red.
Q.Light® Pain care |
| Vascular
Surgeons |
Superficial
vein disorders |
|
| Dermatologists |
Skin
disorder assessment and monitoring |
Q.Light®
Acne, Psoriasis, skin care and Q.Light® Skin Cancer PDT assessment
and treatment filters |
| Physiotherapists |
Monitoring
of tendon and other soft tissue injuries during treatment |
Q.Light®
Pain care |
| General
Surgeons |
Oedema
monitoring permitting early detection of, for example, renal transplant
rejection |
Q.Light®
Wound care with and without infra-red.
Q.Light® Pain care |
| Paramedics/Emergency
Room Staff |
Tissue
trauma and X-ray lucent foreign body, (e.g. glass) detection |
Q.Light®
Wound care with and without infra-red.
Q.Light® Pain care |
| Gynecologists
and Midwives |
Monitoring
and identification of hypersensitive pregnancies |
|
| Dialysis
Nurses |
Assessment
and monitoring of oedema changes during dialysis leading to the more
effective use of equipment |
Q.Light®
Wound care with and without infra-red.
Q.Light® Pain care |
| Orthopedic
Surgeons |
Wound
healing assessment, tendon repairs, Dupuyten's contracture etc. |
Q.Light®
Wound care with and without infra-red.
Q.Light® Pain care |
| Cosmetic
Surgeons |
Monitoring
the softening/thickening of skin prior to and following surgery, cellulite
measurement, assessment of breast implants and liposuction |
Q.Light®
Wound care with and without infra-red.
Q.Light® Pain care Q.Light® Acne, Psoriasis, skin care and
cellulite treatments. |
| Dentists |
Periodontal
disease |
|
| General
Practitioners and District Nurses |
Monitoring
and diagnosis of many of the listed applications in the Community |
Q.Light®
Wound care with and without infra-red.
Q.Light® Pain care Q.Light® Acne, Psoriasis, skin care |
| Sport
Injury Clinics |
Assessment
of tendon and other sports injuries |
Q.Light®
Wound care with and without infra-red.
Q.Light® Pain care |
| Nursing
Home Staff |
Early
diagnosis of pressure ulcers and monitoring of wound healing |
Q.Light®
Wound care with and without infra-red.
Q.Light® Pain care |
| Veterinary |
Assessment
of tendon and ligament injuries, superficial tumour detection etc. |
Q.Light®
Wound care with and without infra-red.
Q.Light® Pain care |
| Pharmaceutical
and Medical Device Industry |
Assessment
of established skin care products and the impact of new products (drugs,
creams etc.) on the skin and underlying soft tissue |
|
EPISCAN® S
y s t e m s p e c i f i c a t i o n
- Various
probes at centre frequencies between 16 & 45 MHz
- 15mm
scan length
- Digitalisation
rate up to 200 million samples per second
- Wireless
and cable net working capability
- CD/DVD
Read/Write ROM
- Multiple
memory card slots
- Blue
tooth enabled
- 17
inch screen (1280 x 1024)
- Footswitch
option
- CE/UL
Certified, US FDA Marketing Clearance obtained
|
- Windows
XP Operating system
- Linear
& area measurement plus text annotation functions
- Integrated
relational database for the patient / image
- record
retention
- Multiple
image viewing
- Image
analysis functions
- Multiple
image viewing palette options
- Image
export as DICOM and BMP files
- Drag
and drop capability including into Microsoft Office programs
- Digital
photographs can be imported
- User
selectable images size up to 1024 x 2048 pixels
|

Episcan®
In Use - OVERVIEW
Longports
high resolution ultrasound system the EPISCAN®-I-200
has been designed to image the skin and underlying few centimetres of
soft tissue with great clarity. Ultrasound of centre frequency as high
as 45 MHz can be utilized to provide clear images of the skins structure,
visualise the impact of many of the diseases and injuries that inflict
this region and monitor the impact of treatments.
The
EPISCAN®
software operates under Windows XP and has been designed to be user friendly
as well as providing the user with a series of features and functions
that allow image annotations and measurements to be performed as well
as comprehensive patient record keeping. Further, digital photographs
can be imported.
The
EPISCAN®
has been designed to occupy a small space in a clinicians office
or treatment area and can positioned on a small trolley or a desk.
Applications
include:
Skin lesion mapping
Monitoring the impact of aesthetic procedures on the skin
Assessing the impact of medications on the skin
Wound and scar assessment
General assessment of skin conditions and diseases and the monitoring
of treatments
30MHz
Image with different palettes employed (a range of palettes are available
through the EPISCAN®
software)

F
E A T U R E S
Many
applications of the EPISCAN®
relate to assessing the impact of a treatment or process, where the user
is looking to measure the differences to result from their intervention
normally over time. The EPISCAN®
offers a series of tools to help quantitatively measure changes that may
occur as well as providing the user with the ability to visually qualitatively
asses sequences of images tiled on the screen.
Most simply quantitative
measurements can be linear measurements or area measurements, for example
measuring dermal thickness. The EPISCAN®
also provides the user with the means to compare the make-up of the reflected
signals that is used to create the images.
Longport has developed
a high frequency ultrasound system that allows clinicians to image the
skin and underlying few centimetres of soft tissue at a very high resolution.
This system called the EPISCAN® enables a non-invasive visualisation
of a wide range of injuries, diseases and conditions, many for the first
time. The EPISCAN® has found applications in a large number of disciplines,
including the appraisal of cosmetic procedures, the mapping of skin lesions
and burn assessment.
Wound assessment
and prevention is, however, proving to be one of the most significant
applications of the EPSICAN®. In this field Longport's technology
has been found to give clinicians three main advantages:
Earlier
Detection of Pressure Ulcers
The EPISCAN®
can visualize soft tissue through to bone at the sites where pressure
ulcers normally develop and image tissue changes that precede the development
of visible pressure ulcer. Significantly, this ultrasound imaging technique
can detect developing pressure ulcers earlier than conventional visual
techniques. Using the EPISCAN®, pressure ulcers have been found
to develop in subcutaneous tissue over a hard prominence, normally a
bone, and then spread out through the dermis to the epidermis, where
at some point, an open wound often develops. Three distinct early phases
(pre Stage 1) of pressure ulcer development can be determined using
the Longport's technology. The three early phases of pressure ulcer
development are shown in the ultrasound images below.
Studies have
shown that the Longport ultrasound phase data can be used to initiate
earlier and more targeted intervention and that this can significantly
reduce the occurrence of open pressure ulcers cost effectively.
It is also possible
to differentiate between friction ulcers (Pic 1 left) and/or
those caused by incontinence and pressure ulcers (Pic 2 Right).

Optimization
of Treatment Protocols
The EPISCAN®
can image through a wound and generate a cross sectional image that
can be assessed like a non-invasive biopsy. The ability to obtain these
non-invasive, but histological-like images is providing clinicians with
valuable data on the state and progression of wounds without the need
for tissue damaging biopsies. The ability of the EPISCAN®
to visualize deep into a wound, including the imaging of the wound bed,
where changes to wound state often originate, and to monitor changes
to this region is allowing clinicians to develop patient specific treatment
protocols in a more timely manner. Image data generated by the EPISCAN®
is therefore helping clinicians to heal chronic wounds faster and more
effectively.
Features such
as sinus tracking, wound undermining, oedema and the presence of foreign
bodies can also be imaged and recorded.
Record
Keeping and Audit
Centres are finding
data generated by the EPISCAN®
to be a useful new record of their activities and the health of their
patients and that these records provide a valuable input into subsequent
audits. This capability has been found to be a particularly valuable
in the assessment of patients on admittance to a facility. Longport's
system has been developed to integrate patient and wound assessment
data (including Braden indexing), treatment protocols in relational
databases together with digital photographic and ultrasound images.
The ability
to generate and maintain a comprehensive electronic record in this way
is expected to reduce a facility's exposure to wound related litigation
and sanctions as well as save staff time.
A
variety of applications are illustrated below:
The
Episcan®
allows for the annotation of images.

Label
areas of interest.
Linear and area measurements
Ultrasound scan of a foreign body (Needle).
Note:
1.
Foreign body distance from skin surface is 3.83 mm.
2. There is an area of inflammation around the needle
of 28.82 sq mm.
3. The needle is in the tissue plain between the dermis
and the deep fascia.
4. Areas of interest are annotated including the probe
membrane, epidermis and the needle.
The
Episcan® allows digital photographs to be imported.

Areas of interest
can be annotated
The location of the each scan can be marked on the photograph
Surface area of the wound can be measured
Wound photographs
demonstrate progressive improvement of wound size.
Day 1: 703.62
sq mm
Day 5: 546.00 sq mm
Day 12: 509.08 sq mm
Day 27: 480.59 sq mm
The
Episcan® allows for the images to be viewed in greyscale or color
palette.
New
Higher Frequency Probe Images
Comparable
High-Resolution Images of Dermal Structure Captured at different Frequencies
A
p p l i c a t i o n E x a m p l e s
Wound
Assessment and Prevention
The EPISCAN®
can be a valuable tool in the assessment of chronic ulcers. It allows
the user to look beneath the wounds for subtle changes that may affect
clinical decision making.
The EPISCAN®
can be used for the following:
Visualization of tissue beneath the wound
Visualization
of wound undermining
Visualization
of sinus tract formation
Visualization
of sub-wound edema
Visualization
of foreign bodies
Documentation
of effectiveness of wound treatments
Visualization
of tissue beneath the wound: Up until now the care giver could
only go by what they saw on the surface of the wound. The EPISCAN®
allows the user to look into and beneath the wound to see what is
occurring. It can aid in determining how deep the wound penetrates
and help to make a judgment on the quality of the tissue beneath the
wound.
Visualization
of wound undermining: It is common for wounds to undermine under
the skin expanding much wider that the wound surface. The EPISCAN®
allows the user to image the peri-wound area to see if it is undermined.
This can change the treatment regime and require more aggressive debridement
or packing of the wound.
Visualization
of sinus tract formation: Sinus tract formation is common in wounds.
In fact since we can see with ultrasound that most wounds begin deep
and then tunnel to the surface it would be expected that many such
wounds have deep sinus tracts. The EPISCAN®
can Visualization of sinus tract. This may necessitate more aggressive
debridement and exploration. This can also make the care giver suspicious
of osteomyelitis and further diagnostic testing may be needed.
Visualization
of sub-wound edema: Many wound care experts and researchers believe
that edema under a wound is a prime reason for slow healing. A variety
of treatments are aimed at reducing this edema. The EPISCAN®
is the perfect tool to monitor the effectiveness of these treatments.
Visualization
of foreign bodies: There are times where there are foreign bodies
within the wound tissue. This could be suture or various other structures.
Examining the wound with the EPISCAN®
could help identify these foreign bodies and also help navigate the
clinician to the location to aid in their removal.
Documentation
of effectiveness of wound treatments: It is more and more important
to document wound prevention and treatment. The EPISCAN is an excellent
tool for this documentation.
The EPISCAN's Role
in Pressure Ulcer Prevention and
Treatment:
Pressure ulcers are a common problem
in any situation where patients are compromised because of immobility,
nutrition, incontinence or age. Preventive measures such as pressure
relief aids, specialized beds and mattresses are expensive and therefore
cannot be used for every patient. Targeting the pressure relief is
a much more cost effective way to manage this problem. By having advanced
knowledge that a pressure ulcer is forming, the care giver can take
the appropriate steps to ward off their development. Pressure ulcers
are also a prime outcome measure for extended care and acute care
facilities. They are a primary cause for litigation and regulatory
sanctions.
"Pressure
ulcer development is an important outcome measure because it is a
common complication, it is largely preventable, and it can be costly
both to patients and to health care providers." US
Department of Health
The
reported incidence of pressure ulcers varies greatly among studies;
however all agree that the incidence should be lower than what presently
exists.
| Location |
Prevelance |
Reference |
|
|
|
| Acute Care |
10.8% |
Barczak 1997 |
| Extended
Care |
12% |
Spector 1998 |
| Community |
29% |
Ot-Giromini
1993 |
Where
a pressure ulcer has formed, Episcan®
can be used to monitor the effect of treatment. Wound closure on the outside
can mask incomplete healing below, leading to premature termination of
treatment and re-eruption of the pressure ulcer. Also Episcan®
also detects wound undermining sideways beneath adjacent healthy skin
and allows nursing staff to administer timely preventive action to stop
the wound spreading.
ADVANTAGES
The advantages of the EPISCAN®
in the prevention of pressure ulcers are as follows:
1. Detection
of pressure ulcers before clinical signs are apparent
2. Documentation of existence of pressure ulcers on admission
3. Targeting treatments to specific anatomical areas
4. Distinguishing between pressure ulcers and friction ulcers
5. Following pre-pressure ulcers to see if treatments are effective
6. Increasing awareness and compliance of staff
Detection of pressure ulcers before clinical signs are apparent:
High
resolution ultrasound has the ability to detect subtle changes in the
fluid content of tissue. It has been demonstrated that the first ultrasound
change that occurs in the formation of a pressure ulcer is edema in
the subcutaneous tissue. This is followed by dermal and sub-epidermal
edema. This information can give the care giver a "heads up"
before the clinical signs of a pressure ulcer are seen. Pressure relief
and skin care can then be targeted before the ulcer has developed further.
Documentation of existence of pressure ulcers on admission:
There
has always been a conflict over who is responsible for the formation
of a pressure ulcer. Very often patients are transferred from one facility
to another with a pressure ulcer already forming. By doing an ultrasound
exam upon admission the receiving facility can document if a pressure
ulcer is already forming. This could reduce liability and regulatory
sanctions and fines.
Targeting of treatments to specific anatomical areas:
Providing pressure relief and skin care to all patients and anatomical
parts is costly, time consuming and often not practical. The EPISCAN®
exam allows for the treatments to target the patient and areas that
need them the most. This can result in better outcomes and more efficient
use of staff and materials.
Distinguishing between pressure ulcers and friction ulcers:
Often,
there is no distinction made between pressure ulcers and friction and
incontinence ulcers, although the treatment regime can be different.
The EPISCAN®
exam can distinguish between types of ulcers. This allows for more effective
treatments of the ulcer.
Following pre-pressure ulcers to see if treatments are effective:
Once
a pressure ulcer is seen developing on ultrasound appropriate care is
initiated to reverse the process. Up until now there has been no effective
way to measure the effectiveness of these modalities. Follow up exams
can document the effectiveness of the treatment given.
Increasing awareness and compliance of staff:
There
was a study performed at Yale University utilizing the EPISCAN®
in the treatment and prevention of pressure ulcers. One of the conclusions
of this study is that it increased the awareness and compliance of the
staff. By demonstrating ultrasound evidence of pressure ulcer formation
staff members are more likely to take clinically appropriate action.
Also, by showing the results of their efforts with improved scans, the
outcomes of their actions are reinforced.
Note: Q.Light
phototherapy is extremely effective in stimulating healing of pressure
sores and chronic wounds. Application is simple and requires no special
training or safety precautions. Just a few minutes daily during change
of dressings can produce remarkable results, which are easily confirmed
by Episcan. Click here for further details
Extended
Care
The Use of the EPISCAN®
in Extended Care Facilities The EPISCAN®
is ideal for use within an extended care facility. Its portability allows
it to be used in patient rooms. Its ease of use makes it possible to do
an exam in a minimal amount of time. The ultimate goal of the use of the
EPISCAN®
in extended care facilities is to reduce the incidence of pressure ulcer
formation.
It is recommended that the use of the EPISCAN®
be incorporated into existing facility skin care protocols. Each patient
should be evaluated by standard indexes (Braden etc.) to determine their
propensity to pressure ulcer formation. Patients that have a high index
rating should have a careful skin evaluation including ultrasound scanning.
The patient is also evaluated for their position, continence and mobility.
High risk anatomical sites are identified, evaluated and scanned. . The
ultrasound examination adds about ten minutes to the standard exam. This
time spent will be more than made up if the incidence of pressure ulcers
is reduced. It has been found that it is ideal to have two people for
this exam. Most of these patients are immobile and it is difficult to
turn and reposition them. A two person team makes it more efficient and
more comfortable for the patient.
Each scan is evaluated to see if there are any signs that a pressure ulcer
is forming. Clinical signs such as non-blanching erythema and bogginess
are noted. Any site that has either ultrasound changes and/or clinical
signs of a pressure ulcer is immediately targeted for treatment. Scans
are labeled and saved in a database for that patient. Patients can be
rescanned as needed. If they continue to be immobile and have other risk
factors examination and scanning should be performed weekly.
Areas that have demonstrated ultrasound changes indicative of pressure
ulcer formation should be scanned on a regular basis to see if treatment
regimes are working.
In existing pressure ulcers the ulcer should be scanned to help aid in
the evaluation of the ulcer. Scans can be repeated as necessary to determine
if treatments are being effective. Digital photographs can also be recorded
for each wound. The EPISCAN®
software allows for accurate measurement of wounds form the digital photographs.
The photographs can also be marked at the location on the wound where
the scan was taken.
The EPISCAN®
can become an integral part of an extended care facilities total care
plan for pressure ulcer prevention and treatment.
Clinical
Dermatology
The EPISCAN®
is able to image the human skin to very high resolution and to differentiate
between subtle changes in tissue structure. Thus it is an ideal tool for
dermatologists to assess various conditions and diseases, determine the
effectiveness of treatments and to help plan surgery.
Skin
Lesion Assessment
High frequency ultrasound can be used to
map skin lesions; enabling clinicians to quantitatively assess the impact
of non-surgical treatments such as photo dynamic therapy (PDT) and to
provide input into surgical planning.
 |
|
|
| |
|
In
addition to imaging the skin high frequency ultrasound can be used
to image nails and nail beds. |
Aesthetics
and Plastics
Longport's EPISCAN ultrasound imaging system
can image the dermal structure to high resolution and with great clarity
enabling subtle changes in tissue structure to be visualised. Thus it
is possible to visualise the effects of ageing, damage caused by sun exposure
and the impact of various aesthetics treatments on the skin. Importantly,
changes before and after treatment can be compared both qualitatively
and quantitatively, allowing the clinician and patient to see the impact
of treatment programs often before visual impact can be seen.
Sun
Induced Damage
Note the increase
thickness of the dermas in the sun exposed image compared with the sun
protected area. Also, the reduced intensity of reflections from the upper,
papillary, region of the dermis in the sun exposed area, indicating a
weaker collagen structure.
The EPISCAN®
is currently being used to evaluate the impact of various skin rejuvenating
laser treatments, where changes in the ultrasound structure of the skin
can often be seen prior to visual changes, fillers, including confirming
that these are injected into the correct plane of the dermis and other
anti-ageing treatments.
The EPISCAN®
can also be used to image cellulite and scar tissue, including keloid
scars.
|
|
|
|
High
Frequency Ultrasound Image of Cellulite
|
High
Frequency Ultrasound Image of Keloid Scar
|
| |
|
Quantitative
Analysis
Many applications of the EPISCAN®
relate to assessing the impact of a treatment or process, where the clinician
is looking to measure the differences to result from their intervention.
The EPISCAN®
offers a series of tools to help quantitatively measure changes that may
occur as well as providing the user with the ability to visually qualitatively
asses sequences of images tiled on the screen. Most simply quantitative
measurements can be linear measurements, for example measuring dermal
thickness. The EPISCAN®
however also provides the user with the means to compare the make-up of
the reflected signals that are used to create the images.
The EPISCAN®
can utilize the signal strength of each pixel, that makes up an image
or area of image, to show subtle changes in tissue characteristics. (Refereed
to here as pixel analysis.) In the following example the same area of
skin before, during and one hour after saturation with a moisturiser was
utilized. One each image an identical area was defined for analysis and
the pixel intensity distribution determined within that defined area.
These
plots show that prior to the application of the moisturizer the average
intensity of the pixels was higher and that one hour after the removal
of the surplus moisturizer there had been a small but measurable change
back towards the pre application condition. (This trend is as expected
as moisturizing or hydrating of the skin lessens the ultrasound reflections.)
This analysis is taken one stage further in the table below where each
of the distribution plots is represented by numeric values.
|
Pre
Moisturizer |
Moisturizer
Applied |
1
hour After Application |
| Median
Intensity |
40
|
29
|
31
|
| Coefficient
of Variation (%) |
91.63
|
103.35
|
99.8
|

The
application of this analysis technique is being investigated to provide
numerical representation of skin ageing or rejuvenation.
IMAGE
LIBRARY
View Images below, or select from
another category
Normal
Tissue
Wounds
Pressure
Ulcers
Clinical
Dermatology
Aesthetics
Normal
Images |
|
 |
35
MHz image of thin skin (anterior thigh) in gray scale including a
hair follicle and its corresponding arrector pili. |
 |
50
MHz image of thin skin (anterior thigh) in gray scale including a
multiple hair follicles. |
 |
Deeper
35 MHz image of the wrist in color palette showing the radial artery. |
 |
35
MHz image of the forearm showing a longitudinal section of tendon
and underlying muscle. |
 |
35
MHz image of thick skin (palm of hand) in color palette demonstrating
the multiple layers of the epidermis. |
 |
Deeper
35 MHz image of thick skin (palm of hand) in color palette including
a subcutaneous blood vessel. |
 |
35
MHz image of nail bed |
| Wounds |
|
 |
Ultrasound
image of an ankle wound seen above taken as indicated by yellow marker.
Image shows minimal edema under wound with no undermining or sinus
tract. |
| Pressure
Ulcers |
|
 |
Image
of the heel showing normal anatomy and reflection off bone. |
 |
Image
of the heel showing pockets of low reflection indicating edema and
suggesting a pre-ulcer caused by pressure. |
 |
mage
of the sacrum showing edema directly under the epidermis suggestive
of a friction ulcer. |
| Clinical
Dermatology |
|
 |
50
MHz image of a skin lesion and adjacent hair follicle |
 |
35MHz
image of skin lesion |
 |
35MHz
image of skin lesion |
 |
35
MHz image of a basal cell carcinoma |
 |
20
MHz image of a squamous cell carcinoma |
| Aesthetics
|
|
 |
35
MHz image of cellulite. Note sculptured edges of the dermis. |
 |
35
MHz image of a keloid. |
 |
mage
(left) of normal skin of the abdomen. Adjacent Image (right) of scar
tissue of the abdomen. |
MEDIA
DOWNLOADS AND REFERENCES
|
|
RECENT
NEWS REPORTING FROM THE UK AND USA
The
British Broadcasting Corporation [The BBC] features Episcan®
in news
reporting www.tissueviability.org/content/default.asp?PageId=128
State
works to ease bedsore problem
Saratoga Springs facility
is among those trying to reduce prevalence of problem in nursing
homes read
article. . .
Medicare
Says It Wont Cover Hospital Errors
WASHINGTON, Aug. 18
In a significant policy change, Bush administration officials
say that Medicare will no longer pay the extra costs of treating
preventable errors, injuries and infections that occur in hospitals,
a move they say could save lives and millions of dollars. read
article. . .
Literature
The Episcan's
use in Wound Care:
Download the PDF
The Episcan's
use in Dermatology: Download
the PDF
Medilux Healthcare
Limited - Epsican®Dermal
Ultrasound Scanner - Brochure
-
Short version [ two pages]
Further
technical information is available on enquiry. s.warren@mediluxhealth.net
All
downloadable files are in Portable Document Format [pdf] and will
require Adobe Reader® to be installed on your computer to open
these files. If you find that the reader programme is not already
installed on your computer you may download the reader for FREE
from the following official download site
|
HIGH
FREQUENCY ULTRASOUND REFERENCES
Akesson
A, Hesselstrand R, Scheja A, Wildt M. Longitudinal development of
skin involvement and reliability of high frequency utltrasound in systemic
sclerosis. Ann Rheum Dis. 2004 Jul; 63(7):791-6
Beagle Gregory L., Bedside Diagnostic Ultrasound and Therapeutic
Ultrasound-guided Procedures in the Intensive Care Setting. Advances in
Critical Care Bedside Procedures. Critical Care Clinics. Vol. 16. No 1.
January 2000.
Calvin M., Modarai B., Young S.R., Koffman G., Dyson M. Pilot study
using high-frequency diagnostic ultrasound to assess surgical wounds in
renal transplant patients. Skin Research and Technology 1997; 3: 60-65.
Chen L, Dyson M, Rymer J, et al. The use of high frequency diagnostic
ultrasound to investigate the effect of hormone replacement therapy on
skin thickness. Skin Research and Technology 2001; 7(2): 95-7.
Chen L., Dyson M., Rymer J., Bolton P.A., Young S.R. The use of
high-frequency diagnostic ultrasound to investigate the effect of hormone
replacement therapy on skin thickness. Skin Research and Technology 2001;
7: 95-97.
Diridollou S, Berson M, Vabre V, et al An in vivo method for measuring
the mechanical properties of the skin using ultrasound. Ultrasound Med
Biol. 1998; Feb;24 (2): 215-24
Dyson M. Advances in wound healing physiology: the comparative
perspective. Veterinary Dermatology 1997, 8, 227-233
Dyson M, Lyder C. Wound management: physical modalities. The Prevention
and Treatment of Pressure Ulcers. Mosby 2001: 177-193
Dyson M., Moodley S., Verjee L., Verling W., Weinman J., Wilson
P. Wound healing assessment using 20 MHz ultrasound and photography. Skin
Research and Technology 2003; 9: 116-121.
Ebrecht M, Hextall J, Kirtley LG, Taylor A, Dyson M, Weinman J
Perceived stress and cortisol levels predict speed of wound healing in
healthy male adults. Psychoneuroendocrinology 2004 jul; 29(6): 798-809
Edsberg Laura E, Cutway, Renee, Anain Shirley, Natiella Joseph
R. Microstructural and mechanical characterization of human tissue at
and adjacent to pressure ulcers. Journal of Rehabilitation Research and
Development. Vol. 37 No. 4, July/August 2000
Foster F. Stuart; Pavlin Charles J., Harasiewicz Kasia A., Christopher
Donald A., Turnbull Daniel H. Advances in Ultrasound Biomicroscopy. Ultrasound
in Med & Biol. Vol. 26, No. 1. pp. 1-27, 2000.
Gniadecka M. Potential for high-frequency ultrasonography, nuclear
magnetic resonance, and Raman spectroscopy for skin studies. Skin Research
and Technology 1997; 3: 139-146.
Gniadecka M. Dermal oedema in lipodermatosclerosis: distribution,
effects of posture and compressive therapy evaluated by high-frequency
ultrsonography. Acta Derm Venereol. 1995; 75(2): 120-124
Gniadecka M. Localization of dermal edema in lipodermatosclerosis,
lymphedema, cardiac insufficiency. High-frequency ultrasound examination
of intradermal echogenicity. J Am Acad Dermatol. 1996; Jul;35(1): 37-41
Gniadecka M, Serup J, Sondergaard. Age-related diurnal changes
of dermal oedema:evaluation by high-frequency ultrasound Br J Dermatol.
1994; Dec;131(6): 849-55
Gniadecka M, Quistorff B. Assessment of dermal water by high-frequency
ultrasound:comparative studies with nuclear magnetic resonance. Br J Dermatol.
1996; Aug;13592): 218-24
Gniadecka M. Effects of ageing on dermal echogenicity. Skin Res
Technol. 2001; August 7(3)204-10
Harland C.C., Bamber J.C., Gusterson B.A., Mortimer P.S. High frequency,
high resolution B-scan ultrasound in the assessment of skin tumors. British
Journal of Dermatology (1993) 128, 525-532.
Hu D., Phan T.T., Cherry G.W., Ryan T.J. Dermal oedema assessed
by high frequency ultrasound in venous leg ulcers. British Journal of
Dermatology 1998: 138: 815-820.
Kelly Dierdre A., Walker Susan L., McGregor Jane M., Young Anthony
R. A single exposure of solar simulated radiation suppresses contact hypersensitivity
responses both locally and systemically in humans: quantitative studies
with high-frequency ultrasound. Journal of Photochemistry and Photobiology.
1998; 130-142.
Kolbe, Ludger, Stoudemayer Tracy, Kligman Albert M. Assessment
of the atrophogenicity of corticosteroids to human skin using non-invasive
methods. Skin Research and Technology 1998; 4: 167-173.
Liffers A, Vogt M, Ermert H. In vivo biomicroscopy of the skin
with high-resolution magnetic resonance imaging and high frequency ultrasound.
Biomed Tech (Berl). 2003 May: 48(5): 130-4
Lopez H, Beer JZ, Miller SA, Zmudzka BZ. Ultrasound measurements
of skin thickness after UV exposure: feasibility study. J Photochem Photobiol
B. 2004 Feb 20; 73(3) 123-32
Karim A, Young SR, Lynch JA, Dyson M. A Novel Method of Assessing
Skin Ultrasound Scans. Wounds. 1994; 6(1), 9-15
Mirpuri N.G., Dyson M., Rymer J., Bolton P.A., Young S.R. High-frequency
ultrasound imaging of the skin during normal and hypertensive pregnancies.
Skin Research and Technology 2001; 7: 65-69.
Mogensen S., Hertig J. Stopping Pressure Ulcers - Before They Start.
Nursing Homes Magazine. 2004; Vol 53, No. 5
Overgaard OL, Takimaki H, Serup J. High-frequency ultrasound characterization
of normal skin. Skin thickness and echographic density of 22 anatomical
sites. Skin Res Technol. 1995; 1, 74-80
Peer S., Bodner G., Meirer R., Willeit J., Piza-Katzer, H. Examination
of Postoperative Peripheral Nerve Lesions with High-Resolution Sonography.
American Journal of Roentgenology.2001 Feb; 177: 415-419.
Raju B I, Swindells KJ, Gonzalez S, Srinivasan MA. Quantitative
ultrasonic methods for characterization of skin lesions in vivo. Ultrasound
Med Biol.2003 Jun; 29(6):825-38
Rippon M.G., Springett K., Walmsley R., Patrick K., Millson S.
Ultrasound assessment of skin and wound tissue: comparison with histology.
Skin Research and Technology 1998; 4: 147-154.
Salcido R, Donofrio JC, Fisher SB, LeGrand EK, Dickey K, Carney
JM, Schosser R, Liang R. Histopathology of pressure ulcers as a result
of sequential computer-controlled pressure sessions in a fuzzy rat model.
Adv Wound Care 1994 Sep; 7(5):23-4, 26, 28 passium
Salcido, R. Advances in Skin & Wound Care. 2000 Mar. www.woundcarenet.com/advances/articles/00marapredit.htm
Sanby-Moller J, Wulf HC. Ultrasonographic subepidermal low-echogenic
band, dependence of age and body site. Skin Res Technolo. 2004 Feb;10
(1):57-63
Schou A.J., Thompsen K., Plomgaard A.M., Wolthers O.D. Methodological
aspects of high-frequency ultrasound of skin in children. Skin Research
and Technology. 2004 August; 10 (3): 200.
Seidenari S, Pagnoni A, DiNardo A, et al Echographic evaluation
with image analysis of normal skin variations according to age and sex.
Skin Pharmacol. 1994; 7(4): 201-9
Serup J., Keiding J., Fullerton A., Gniadecka M.,Gniadecka R. High
Frequency Ultrasound Examination of Skin: Introduction and Guide. Ch.
12.1: 239-354.
Vogt M, Knuttel A, Hoffman K, Altmeyer P, Ermert H. Comparison
of high frequency ultrasound and optical coherence tomography as modalities
for high resolution and non invasive skin imaging. Biomed Tech (Berl).
2003 May; 48(5):116-21
Whiston R.J., Young S.R., Lynch J.A., Harding K.G., Dyson, M. Application
of high frequency ultrasound to the objective assessment of healing wounds.
Wounds. 1993
Whiston RJ, Melhuish J, Harding KG. High Resolution Ultrasound
Imaging in Wound Healing. Wounds. 1993; A Compendium of Clinical Research
and Practice; 116-121
Yang Y, Jia C, Cherry GW, Fu X, Li J. Long-term mortality of ultrasound
structure in patients with venous leg ulcers-healed from one week to twenty
years. Chin Med J (Engl).2002 Dec; 115(12):1819-23
Zhou Y., Stuart Foster F., Nieman B.J., Davidson L., Josette Chen
L., Mark Henkelman R.Comprehensive transthoracic cardiac imaging in mice
using ultrasound biomicroscopy with anatomical confirmation by magnetic
resonance imaging. Physiol Genomics. 2004 April; 18: 232-244.
For
more references and information on training courses for general practitioners
and other medical personnel please visit the training
section of this site.
PRIVACY
STATEMENT
(c)
Medilux Healthcare Limited. 2003 - 2008. All rights reserved
VAT No 887 9818 33 Comp Reg 5925249 Webmaster
- Steven Warren s.warren@mediluxhealth.net.
Medilux
Healthcare Limited is a specialised marketing company. We promote devices
on the basis of the Manufacturers' representations as to quality and efficacy
and where possible we provide additional information as to the conditions
which may benefit from their use but we do not guarantee that they will
be suitable or effective for all purchasers. We do not examine or diagnose
patients or recommend treatments and where we promote medical services
this is on an information-only basis. Patients contract directly with
these providers and all clinical decisions are made by them alone.
All rights reserved. Any
unauthorised copying, duplication, or distribution in whole or in part,
by any means, including electronic copying, is a violation of this copyright.
|
|